15 Einträge gefunden

1. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma

   1. König, Alexandra M
   2. Reeh, Matthias
   3. Dancau, Ana Maria
   4. Rathjens, Merrit
   5. Gros, Stephanie
   6. Uzunoglu, Faik G
   7. Bockhorn, Maximilian

   2013 - Forschungsinformationssystem des UKE
2. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma

   1. Gröbe, Alexander
   2. Hanken, Henning
   3. Kluwe, Lan
   4. Schöllchen, Maximilian
   5. Tribius, Silke
   6. Pohlenz, Philipp
   7. Clauditz, Till

   2013 - Forschungsinformationssystem des UKE
3. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
4. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE
5. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

   1. Burandt, Eike Christian
   2. Jens, G
   3. Holst, Frederik
   4. Jänicke, Fritz
   5. Müller, Volkmar
   6. Quaas, Alexander
   7. Choschzick, Matthias

   2013 - Forschungsinformationssystem des UKE
6. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

   1. Sirma, Hüseyin
   2. Broemel, Margarethe
   3. Stumm, Laura
   4. Tsourlakis, Maria Christina
   5. Steurer, Stefan
   6. Tennstedt, Pierre
   7. Salomon, Georg

   2013 - Forschungsinformationssystem des UKE
7. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma

   1. Tennstedt, Pierre
   2. Fresow, Robert
   3. Simon, Ronald
   4. Marx, Andreas
   5. Terracciano, Luigi
   6. Petersen, Cordula
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
8. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

   1. Jacobsen, Frank
   2. Ashtiani, Sharad Nouraie
   3. Tennstedt, Pierre
   4. Heinzer, Hans
   5. Simon, Ronald
   6. Sauter, Guido
   7. Sirma, Hüseyin

   2013 - Forschungsinformationssystem des UKE
9. High mitochondria content is associated with prostate cancer disease progression

   1. Grupp, Katharina
   2. Jedrzejewska, Karolina
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Quaas, Alexander

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
10. HER2 amplification in squamous cell carcinomas of the vulva

    1. Choschzick, Matthias
    2. Hess, Stephan
    3. Grob, Tobias
    4. Burandt, Eike
    5. Wölber, Linn
    6. Simon, Ronald
    7. Sauter, Guido

    2013 - Forschungsinformationssystem des UKE
11. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC)

    1. Blessmann, Marco
    2. Al-Dam, Ahmed
    3. Hanken, Henning
    4. Assaf, Alexandre T
    5. Riecke, Björn
    6. Klatt, Jan
    7. Simon, Ronald

    2013 - Forschungsinformationssystem des UKE
12. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

    1. Flammiger, Anna
    2. Weisbach, Lars
    3. Huland, Hartwig
    4. Tennstedt, Pierre
    5. Simon, Ronald
    6. Minner, Sarah
    7. Bokemeyer, Carsten

    2013 - Forschungsinformationssystem des UKE
13. Marked heterogeneity of ERG expression in large primary prostate cancers.

    1. Minner, Sarah
    2. Gärtner, Michael
    3. Freudenthaler, Fabian
    4. Bauer, Melanie
    5. Kluth, Martina
    6. Salomon, Georg
    7. Heinzer, Hans

    2013 - Forschungsinformationssystem des UKE
14. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

    1. Müller, Juliane
    2. Ehlers, Arne
    3. Burkhardt, Lia
    4. Sirma, Hüseyin
    5. Steuber, Thomas
    6. Graefen, Markus
    7. Sauter, Guido

    2013 - Forschungsinformationssystem des UKE
15. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

    1. Tsourlakis, Maria Christina
    2. Schoop, Michael
    3. Plaß, Christoph
    4. Huland, Hartwig
    5. Graefen, Markus
    6. Steuber, Thomas
    7. Schlomm, Thorsten

    2013 - Forschungsinformationssystem des UKE